Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglycogen phosphorylase activity

PYGB PYGM

1.36e-0431352GO:0008184
GeneOntologyMolecularFunctionphosphatase activity

PNKP NT5DC4 PFKFB4 INPP5F PPM1H PTPRF SBF1 PTPRM TNS3

1.49e-042871359GO:0016791
GeneOntologyBiologicalProcessdendrite self-avoidance

CNTN4 CNTN6 TNN CNTN5

4.86e-06181344GO:0070593
GeneOntologyBiologicalProcessaxon development

CNTN4 GPM6B KREMEN1 FN1 LAMB1 INPP5F ZDHHC17 CNTN6 HMCN2 PTPRF MEGF8 PTPRM TNN CNTN5 SOS1

1.89e-0564213415GO:0061564
GeneOntologyBiologicalProcessneuron projection development

CNTN4 GPM6B KREMEN1 FN1 FAT3 OBSL1 LAMB1 INPP5F ZDHHC17 CNTN6 HMCN2 PTPRF MEGF8 PTPRM TNN CNTN5 CNTN3 ELMOD3 TNXB VPS13B ARHGAP33 SOS1

2.73e-05128513422GO:0031175
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

CNTN4 PCDHGA3 FAT3 CNTN6 HMCN2 PTPRF PTPRM CNTN5

3.09e-051871348GO:0007156
GeneOntologyBiologicalProcessextracellular matrix organization

GPM6B FN1 ADAM15 LAMB1 COLGALT2 MELTF AEBP1 ACAN LPA TNXB SMAD3

3.63e-0537713411GO:0030198
GeneOntologyBiologicalProcessextracellular structure organization

GPM6B FN1 ADAM15 LAMB1 COLGALT2 MELTF AEBP1 ACAN LPA TNXB SMAD3

3.72e-0537813411GO:0043062
GeneOntologyBiologicalProcessexternal encapsulating structure organization

GPM6B FN1 ADAM15 LAMB1 COLGALT2 MELTF AEBP1 ACAN LPA TNXB SMAD3

3.81e-0537913411GO:0045229
GeneOntologyBiologicalProcessneuron recognition

CNTN4 CNTN6 MEGF8 TNN CNTN5

4.06e-05591345GO:0008038
GeneOntologyBiologicalProcessneuron development

CNTN4 GPM6B KREMEN1 FN1 FAT3 OBSL1 LAMB1 INPP5F ZDHHC17 GBA2 CNTN6 HMCN2 PTPRF MEGF8 PTPRM TNN CNTN5 CNTN3 ELMOD3 TNXB VPS13B ARHGAP33 SOS1

6.58e-05146313423GO:0048666
GeneOntologyBiologicalProcesscell-substrate adhesion

GPM6B MYADM FN1 ADAM15 LAMB1 MELTF LPA TNN KIF14 TNXB SMAD3

7.72e-0541013411GO:0031589
GeneOntologyBiologicalProcesscell morphogenesis involved in neuron differentiation

CNTN4 FN1 FAT3 OBSL1 LAMB1 ZDHHC17 CNTN6 HMCN2 PTPRF MEGF8 PTPRM TNN CNTN5 ARHGAP33 SOS1

1.07e-0474813415GO:0048667
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

CNTN4 MYADM PCDHGA3 FAT3 CNTN6 HMCN2 PTPRF PTPRM CNTN5

2.11e-043131349GO:0098742
GeneOntologyBiologicalProcessregulation of extracellular matrix organization

LAMB1 MELTF AEBP1 TNXB SMAD3

2.20e-04841345GO:1903053
GeneOntologyCellularComponentprotein complex involved in cell-matrix adhesion

LAMB1 TNN TNXB

1.68e-04171353GO:0098637
GeneOntologyCellularComponenttenascin complex

TNN TNXB

2.46e-0441352GO:0090733
HumanPhenoOsteochondritis dissecans

ACAN SMAD2 SMAD3

2.05e-057443HP:0010886
DomainFN3

IL10RB CNTN4 FN1 OBSL1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1 IL9R

1.35e-0919913013PS50853
DomainFN3_dom

IL10RB CNTN4 FN1 OBSL1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1 IL9R

2.46e-0920913013IPR003961
DomainFN3

IL10RB CNTN4 FN1 OBSL1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1

6.50e-0918513012SM00060
Domainfn3

CNTN4 FN1 OBSL1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1

1.78e-0816213011PF00041
DomainEGF-like_CS

FN1 ADAM15 FAT3 LAMB1 CUBN HMCN2 MEGF8 TNN TNXB SORL1

1.46e-0526113010IPR013032
DomainCUB

TMPRSS15 KREMEN1 CDCP2 CUBN MEGF8

2.26e-05491305PF00431
DomainCUB

TMPRSS15 KREMEN1 CDCP2 CUBN MEGF8

2.49e-05501305SM00042
Domain-

TMPRSS15 KREMEN1 CDCP2 CUBN MEGF8

3.02e-055213052.60.120.290
DomainCUB

TMPRSS15 KREMEN1 CDCP2 CUBN MEGF8

3.32e-05531305PS01180
DomainCUB_dom

TMPRSS15 KREMEN1 CDCP2 CUBN MEGF8

4.74e-05571305IPR000859
DomainEGF-like_dom

ADAM15 FAT3 LAMB1 CUBN HMCN2 MEGF8 TNN TNXB SORL1

6.24e-052491309IPR000742
DomainKringle-like

KREMEN1 FN1 PRSS12 LPA

6.93e-05321304IPR013806
DomainEGF_1

FN1 ADAM15 FAT3 LAMB1 CUBN HMCN2 MEGF8 TNN TNXB

7.50e-052551309PS00022
DomainEGF_2

ADAM15 FAT3 LAMB1 CUBN HMCN2 MEGF8 TNN TNXB SORL1

1.01e-042651309PS01186
DomainGrowth_fac_rcpt_

LAMB1 CUBN HMCN2 MEGF8 TNN ELAPOR1 TNXB

1.11e-041561307IPR009030
DomainIg-like_fold

IL10RB CNTN4 FN1 HLA-DRB3 OBSL1 CNTN6 HMCN2 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1 IL9R

1.19e-0470613015IPR013783
DomainPHOSPHORYLASE

PYGB PYGM

1.44e-0431302PS00102
DomainGlycg_phsphrylas

PYGB PYGM

1.44e-0431302IPR011833
DomainGlyco_trans_35

PYGB PYGM

1.44e-0431302IPR000811
DomainPhosphorylase

PYGB PYGM

1.44e-0431302PF00343
DomainKringle_CS

KREMEN1 PRSS12 LPA

2.09e-04171303IPR018056
DomainKRINGLE_1

KREMEN1 PRSS12 LPA

2.09e-04171303PS00021
DomainKR

KREMEN1 PRSS12 LPA

2.09e-04171303SM00130
DomainKringle

KREMEN1 PRSS12 LPA

2.09e-04171303IPR000001
DomainKRINGLE_2

KREMEN1 PRSS12 LPA

2.09e-04171303PS50070
DomainKringle

KREMEN1 PRSS12 LPA

2.09e-04171303PF00051
Domain-

IL10RB CNTN4 FN1 HLA-DRB3 OBSL1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1 IL9R

2.16e-04663130142.60.40.10
DomainEGF

ADAM15 FAT3 LAMB1 CUBN MEGF8 TNN TNXB SORL1

2.43e-042351308SM00181
DomainEGF_3

ADAM15 FAT3 CUBN HMCN2 MEGF8 TNN TNXB SORL1

2.43e-042351308PS50026
DomainIg_I-set

CNTN4 OBSL1 CNTN6 HMCN2 PTPRF CNTN5 CNTN3

3.72e-041901307IPR013098
DomainI-set

CNTN4 OBSL1 CNTN6 HMCN2 PTPRF CNTN5 CNTN3

3.72e-041901307PF07679
DomainSMAD_FHA_domain

PNKP KIF14 SMAD2 SMAD3

4.68e-04521304IPR008984
DomainPD_growth_factor_CS

PGF VEGFB

9.87e-0471302IPR023581
DomainIGc2

CNTN4 OBSL1 CNTN6 HMCN2 PTPRF CNTN5 CNTN3

1.30e-032351307SM00408
DomainIg_sub2

CNTN4 OBSL1 CNTN6 HMCN2 PTPRF CNTN5 CNTN3

1.30e-032351307IPR003598
DomainDWB

SMAD2 SMAD3

1.31e-0381302SM00524
DomainMH2

SMAD2 SMAD3

1.31e-0381302PS51076
DomainMH1

SMAD2 SMAD3

1.31e-0381302PS51075
Domain-

SMAD2 SMAD3

1.31e-03813023.90.520.10
DomainMAD_homology_MH1

SMAD2 SMAD3

1.31e-0381302IPR013019
DomainDwarfin

SMAD2 SMAD3

1.31e-0381302IPR013790
DomainMH2

SMAD2 SMAD3

1.31e-0381302PF03166
DomainSMAD_dom_Dwarfin-type

SMAD2 SMAD3

1.31e-0381302IPR001132
DomainPDGF_1

PGF VEGFB

1.68e-0391302PS00249
DomainPDGF

PGF VEGFB

1.68e-0391302SM00141
DomainPDGF

PGF VEGFB

1.68e-0391302PF00341
DomainPDGF_2

PGF VEGFB

1.68e-0391302PS50278
DomainPDGF/VEGF_dom

PGF VEGFB

1.68e-0391302IPR000072
DomainMAD_homology1_Dwarfin-type

SMAD2 SMAD3

3.03e-03121302IPR003619
DomainDWA

SMAD2 SMAD3

3.03e-03121302SM00523
DomainEGF_dom

CUBN MEGF8

3.03e-03121302IPR024731
DomainEGF_3

CUBN MEGF8

3.03e-03121302PF12947
DomainMH1

SMAD2 SMAD3

3.03e-03121302PF03165
DomainEGF_CA

FAT3 CUBN HMCN2 MEGF8

3.06e-03861304PF07645
Domain6-hairpin_glycosidase-like

GBA2 PHKB

3.57e-03131302IPR008928
Domain6-blade_b-propeller_TolB-like

HHIPL2 EIF3B SORL1

4.02e-03461303IPR011042
Domain-

MEGF8 KBTBD11 KLHL34

4.53e-034813032.120.10.80
DomainEGF_Ca-bd_CS

FAT3 CUBN HMCN2 MEGF8

4.71e-03971304IPR018097
DomainEGF_CA

FAT3 CUBN HMCN2 MEGF8

5.07e-03991304PS01187
DomainProt-tyrosine_phosphatase-like

PTPRF SBF1 PTPRM TNS3

5.07e-03991304IPR029021
DomainASX_HYDROXYL

FAT3 CUBN HMCN2 MEGF8

5.25e-031001304PS00010
DomainMAM_1

TMPRSS15 PTPRM

5.41e-03161302PS00740
DomainSMAD_dom-like

SMAD2 SMAD3

5.41e-03161302IPR017855
Domain-

SMAD2 SMAD3

5.41e-031613022.60.200.10
DomainAa_trans

TMEM104 SLC38A10

6.11e-03171302PF01490
DomainAA_transpt_TM

TMEM104 SLC38A10

6.11e-03171302IPR013057
DomainMAM

TMPRSS15 PTPRM

6.11e-03171302SM00137
DomainEGF-type_Asp/Asn_hydroxyl_site

FAT3 CUBN HMCN2 MEGF8

6.44e-031061304IPR000152
DomainKelch-typ_b-propeller

MEGF8 KBTBD11 KLHL34

6.64e-03551303IPR015915
DomainMAM

TMPRSS15 PTPRM

6.84e-03181302PF00629
DomainMAM_dom

TMPRSS15 PTPRM

6.84e-03181302IPR000998
DomainMAM_2

TMPRSS15 PTPRM

6.84e-03181302PS50060
PathwayWP_FOCAL_ADHESION

FN1 LAMB1 PGF MAPK12 TNN TNXB SOS1 VEGFB

3.21e-05187938MM15913
PathwayREACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS

PHKB PYGB PYGM

9.60e-0514933M19193
PathwayREACTOME_ECM_PROTEOGLYCANS

FN1 LAMB1 ACAN TNN TNXB

1.43e-0476935M27219
PathwayWP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING

FN1 LAMB1 PFKFB4 PGF TNN IRS2 TNXB SOS1 VEGFB

1.68e-04302939M39719
PathwayWP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION

FN1 SMAD2 SMAD3

2.49e-0419933M39370
PathwayREACTOME_ECM_PROTEOGLYCANS

FN1 ACAN TNN TNXB

2.55e-0447934MM14925
PathwayKEGG_INSULIN_SIGNALING_PATHWAY

PHKB PTPRF PYGB PYGM IRS2 SOS1

2.88e-04137936M18155
PathwayWP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY

FN1 LAMB1 PFKFB4 PGF TNN IRS2 TNXB SOS1 VEGFB

2.96e-04326939MM15917
PathwayWP_FOCAL_ADHESION

FN1 LAMB1 PGF TNN TNXB SOS1 VEGFB

3.42e-04199937M39402
PathwayKEGG_FOCAL_ADHESION

FN1 LAMB1 PGF TNN TNXB SOS1 VEGFB

3.42e-04199937M7253
Pubmed

Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues.

CNTN4 CNTN6 CNTN5 CNTN3

1.12e-095136427539848
Pubmed

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

CNTN4 FN1 ANPEP LAMB1 PTPRF MEGF8 PTPRM ACAN TNN CNTN3 TNXB

6.25e-092571361116335952
Pubmed

A role for Nr-CAM in the patterning of binocular visual pathways.

CNTN4 CNTN6 CNTN5 CNTN3

1.08e-0712136416701205
Pubmed

Pioneering axons regulate neuronal polarization in the developing cerebral cortex.

CNTN4 CNTN6 CNTN5 CNTN3

1.56e-0713136424559674
Pubmed

Glycoprotein M6B Interacts with TβRI to Activate TGF-β-Smad2/3 Signaling and Promote Smooth Muscle Cell Differentiation.

GPM6B SMAD2 SMAD3

2.33e-074136330372567
Pubmed

Mstn knockdown decreases the trans-differentiation from myocytes to adipocytes by reducing Jmjd3 expression via the SMAD2/SMAD3 complex.

KDM6B SMAD2 SMAD3

2.33e-074136331334687
Pubmed

Progenitor-like cells contributing to cellular heterogeneity in the nucleus pulposus are lost in intervertebral disc degeneration.

MELTF ACAN SMAD2 SMAD3

5.12e-0717136438865240
Pubmed

Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system.

CNTN4 CNTN5 CNTN3

5.82e-075136318272596
Pubmed

Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes.

KDM6B SMAD2 SMAD3

1.16e-066136320571128
Pubmed

Galectin-1 stimulates motility of human umbilical cord blood-derived mesenchymal stem cells by downregulation of smad2/3-dependent collagen 3/5 and upregulation of NF-κB-dependent fibronectin/laminin 5 expression.

FN1 SMAD2 SMAD3

3.23e-068136324503541
Pubmed

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

FHL1 SMAD2 SMAD3

3.23e-068136319139564
Pubmed

Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.

CNTN4 OBSL1 CNTN6 PTPRF PTPRM CNTN5 CNTN3

3.68e-06162136725826454
Pubmed

Comparative interactome analysis of α-arrestin families in human and Drosophila.

MON2 MYADM USP11 NCBP1 INPP5F TRIM5 IPO9 PTPRF SVIL

4.25e-06313136938270169
Pubmed

Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling.

ACAN SMAD2 SMAD3

4.83e-069136325155999
Pubmed

Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.

RIN1 MAVS IRS2 TNS3 SMAD3 SOS1

4.91e-06110136637219487
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

NSUN4 PNKP ZCWPW1 L3MBTL2 USP11 OBSL1 TCERG1 PES1 SPIDR FHL1 PRDM6 SMAD2 SMAD3 SORL1

7.25e-068571361425609649
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

FNIP2 IL10RB TMPRSS15 L3MBTL2 USP11 MKRN2 SLC30A8 PFKFB4 GBA2 ROPN1L SLC38A10 EHBP1L1 PGAP2 CBX1 RASAL2 DOP1B MPG

7.56e-0612421361730973865
Pubmed

Versican facilitates chondrocyte differentiation and regulates joint morphogenesis.

ACAN SMAD2 SMAD3

9.43e-0611136320404343
Pubmed

Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart.

ACAN SMAD2 SMAD3

1.25e-0512136318296617
Pubmed

Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

SMAD2 SMAD3

1.52e-052136236050359
Pubmed

Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development.

SMAD2 SMAD3

1.52e-052136211984875
Pubmed

Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming.

SMAD2 SMAD3

1.52e-052136223666711
Pubmed

Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.

SMAD2 SMAD3

1.52e-052136218210139
Pubmed

Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.

SMAD2 SMAD3

1.52e-052136220010874
Pubmed

Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.

SMAD2 SMAD3

1.52e-052136216382155
Pubmed

Multidirectional and multizonal tangential migration of GABAergic interneurons in the developing cerebral cortex.

GAD1 SMAD3

1.52e-052136216672340
Pubmed

Outcome of lumbar epidural steroid injection is predicted by assay of a complex of fibronectin and aggrecan from epidural lavage.

FN1 ACAN

1.52e-052136221224775
Pubmed

Evidence for a role of Smad3 and Smad2 in stabilization of the tumor-derived mutant Smad2.Q407R.

SMAD2 SMAD3

1.52e-052136212700238
Pubmed

Asthma-derived fibroblast to myofibroblast transition is enhanced in comparison to fibroblasts derived from non-asthmatic patients in 3D in vitro culture due to Smad2/3 signalling.

SMAD2 SMAD3

1.52e-052136233245228
Pubmed

Formation of the definitive endoderm in mouse is a Smad2-dependent process.

SMAD2 SMAD3

1.52e-052136210862745
Pubmed

Smad2-dependent downregulation of miR-30 is required for TGF-β-induced apoptosis in podocytes.

SMAD2 SMAD3

1.52e-052136224086574
Pubmed

Specific Smad2/3 Linker Phosphorylation Indicates Esophageal Non-neoplastic and Neoplastic Stem-Like Cells and Neoplastic Development.

SMAD2 SMAD3

1.52e-052136232705438
Pubmed

Smad2/3 Linker Phosphorylation Is a Possible Marker of Pancreatic Stem/Progenitor Cells in the Regenerative Phase of Acute Pancreatitis.

SMAD2 SMAD3

1.52e-052136228099259
Pubmed

Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation.

SMAD2 SMAD3

1.52e-052136226354774
Pubmed

PTPRM methylation induced by FN1 promotes the development of glioblastoma by activating STAT3 signalling.

FN1 PTPRM

1.52e-052136234225581
Pubmed

Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium.

SMAD2 SMAD3

1.52e-052136235780861
Pubmed

Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming.

SMAD2 SMAD3

1.52e-052136229174331
Pubmed

Reorganization of GABAergic circuits maintains GABAA receptor-mediated transmission onto CA1 interneurons in alpha1-subunit-null mice.

GAD1 GABRA1

1.52e-052136217552997
Pubmed

Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it.

FN1 LPA

1.52e-05213622531657
Pubmed

SMAD2/3 Phosphorylation Is Downregulated in T Cells in HIV-Infected Patients.

SMAD2 SMAD3

1.52e-052136236226468
Pubmed

Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle.

SMAD2 SMAD3

1.52e-052136225185661
Pubmed

Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.

SMAD2 SMAD3

1.52e-052136222228025
Pubmed

Oocyte-secreted factor activation of SMAD 2/3 signaling enables initiation of mouse cumulus cell expansion.

SMAD2 SMAD3

1.52e-052136217192514
Pubmed

TGFβ pathway deregulation and abnormal phospho-SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis-Dutch type.

SMAD2 SMAD3

1.52e-052136228557134
Pubmed

Differential activation of noncanonical SMAD2/SMAD3 signaling by bone morphogenetic proteins causes disproportionate induction of hyaluronan production in immortalized human granulosa cells.

SMAD2 SMAD3

1.52e-052136226992562
Pubmed

Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury.

SMAD2 SMAD3

1.52e-052136215972691
Pubmed

Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease.

SMAD2 SMAD3

1.52e-052136221732483
Pubmed

Smad2 and 3 transcription factors control muscle mass in adulthood.

SMAD2 SMAD3

1.52e-052136219357234
Pubmed

Evaluation of the Diagnostic and Predictive Value of Glutamic Acid Decarboxylase, Zinc Transporter 8 Serum Levels in Alzheimer's Disease.

GAD1 SLC30A8

1.52e-052136235023669
Pubmed

Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification.

SMAD2 SMAD3

1.52e-052136226905010
Pubmed

Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells.

SMAD2 SMAD3

1.52e-052136221496353
Pubmed

Reduction of Smad2 caused by oxidative stress leads to necrotic death of hypertrophic chondrocytes associated with an endemic osteoarthritis.

SMAD2 SMAD3

1.52e-052136233769459
Pubmed

Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.

SMAD2 SMAD3

1.52e-052136215665291
Pubmed

Inhibiting Smad2/3 signaling in pluripotent mouse embryonic stem cells enhances endoderm formation by increasing transcriptional priming of lineage-specifying target genes.

SMAD2 SMAD3

1.52e-052136227012147
Pubmed

Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.

SMAD2 SMAD3

1.52e-052136224925688
Pubmed

Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.

SMAD2 SMAD3

1.52e-052136215520018
Pubmed

Nuclear exclusion of SMAD2/3 in granulosa cells is associated with primordial follicle activation in the mouse ovary.

SMAD2 SMAD3

1.52e-052136230111581
Pubmed

The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation.

SMAD2 SMAD3

1.52e-052136217074756
Pubmed

Molecular validation of the precision-cut kidney slice (PCKS) model of renal fibrosis through assessment of TGF-β1-induced Smad and p38/ERK signaling.

SMAD2 SMAD3

1.52e-052136226919280
Pubmed

Smad2 and Smad3 expressed in skeletal muscle promote immobilization-induced bone atrophy in mice.

SMAD2 SMAD3

1.52e-052136234710825
Pubmed

Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin.

FN1 LPA

1.52e-052136216150826
Pubmed

Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.

SMAD2 SMAD3

1.52e-052136228666967
Pubmed

The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis.

SMAD2 SMAD3

1.52e-052136221229365
Pubmed

Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation.

SMAD2 SMAD3

1.52e-052136222385658
Pubmed

Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile.

SMAD2 SMAD3

1.52e-052136215630024
Pubmed

Implication of Smad2 and Smad3 in transforming growth factor-β-induced posterior capsular opacification of human lens epithelial cells.

SMAD2 SMAD3

1.52e-052136224911914
Pubmed

Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells.

SMAD2 SMAD3

1.52e-052136219172185
Pubmed

The role of a Williams-Beuren syndrome-associated helix-loop-helix domain-containing transcription factor in activin/nodal signaling.

SMAD2 SMAD3

1.52e-052136211937490
Pubmed

The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.

SMAD2 SMAD3

1.52e-052136215133179
Pubmed

Oocytes determine cumulus cell lineage in mouse ovarian follicles.

SMAD2 SMAD3

1.52e-052136217389684
Pubmed

[Expression and significance of Smad2/3 and HPV16 E7 in cervical intraepithelial neoplasia and cervical carcinoma].

SMAD2 SMAD3

1.52e-052136217927854
Pubmed

Hydrophobic patches on SMAD2 and SMAD3 determine selective binding to cofactors.

SMAD2 SMAD3

1.52e-052136229588413
Pubmed

Neovibsanin B increases extracellular matrix proteins in optic nerve head cells via activation of Smad signalling pathway.

SMAD2 SMAD3

1.52e-052136226045877
Pubmed

Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.

PYGB PYGM

1.52e-052136225130497
Pubmed

Smad2/3 Activation Regulates Smad1/5/8 Signaling via a Negative Feedback Loop to Inhibit 3T3-L1 Adipogenesis.

SMAD2 SMAD3

1.52e-052136234445177
Pubmed

Essential role of Smad3 in angiotensin II-induced vascular fibrosis.

SMAD2 SMAD3

1.52e-052136216556868
Pubmed

Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle.

SMAD2 SMAD3

1.52e-052136221883378
Pubmed

[The roles of Smad 2/3 in transforming growth factor-beta 1 signaling in human dental pulp cells].

SMAD2 SMAD3

1.52e-052136212760775
Pubmed

Differential Role of Smad2 and Smad3 in the Acquisition of an Endovascular Trophoblast-Like Phenotype and Preeclampsia.

SMAD2 SMAD3

1.52e-052136232733385
Pubmed

Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer.

SMAD2 SMAD3

1.52e-052136225908723
Pubmed

The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent.

GAD1 GABRA1

1.52e-052136210501176
Pubmed

Expression pattern and phosphorylation status of Smad2/3 in different subtypes of human first trimester trophoblast.

SMAD2 SMAD3

1.52e-052136228864007
Pubmed

Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.

FN1 LAMB1 HMCN2 AEBP1 ACAN TNXB

2.48e-05146136627068509
Pubmed

Essential roles of fibronectin in the development of the left-right embryonic body plan.

FN1 SMAD2 SMAD3

2.57e-0515136321466802
Pubmed

Muscleblind-like 1 is required for normal heart valve development in vivo.

FN1 ACAN SMAD2

2.57e-0515136326472242
Pubmed

Tbx1 genetically interacts with the transforming growth factor-β/bone morphogenetic protein inhibitor Smad7 during great vessel remodeling.

FN1 SMAD2 SMAD3

2.57e-0515136323011393
Pubmed

Extracellular Matrix Disorganization Caused by ADAMTS16 Deficiency Leads to Bicuspid Aortic Valve With Raphe Formation.

FN1 ACAN SMAD2

2.57e-0515136338018454
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

DPP7 PRUNE2 ANPEP L3MBTL2 PCDHGA3 OBSL1 LAMB1 PFKFB4 PES1 KIF14

2.72e-054961361031343991
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

FNIP2 MON2 JPH1 MAVS MEGF8 MACO1 VPS13B RASAL2 SMAD2 DOP1B

3.12e-055041361034432599
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MON2 USP11 FAT3 TAF1C OBSL1 LAMB1 ECT2L JPH1 HMCN2 ACTL8 CBX1 IRS2 ARHGAP33 SORL1 SOS1

3.32e-0511161361531753913
Pubmed

Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

FN1 SMAD2 SMAD3

3.82e-0517136327398409
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CNTN4 FN1 USP11 TAF1C OBSL1 LAMB1 NCBP1 KDM6B TRIM5 JPH1 TCERG1 FHL1 RASAL2 SMAD2 DOP1B SOS1

4.47e-0512851361635914814
Pubmed

Prox1 ablation in hepatic progenitors causes defective hepatocyte specification and increases biliary cell commitment.

FN1 LAMB1 SMAD2 SMAD3

4.48e-0550136424449835
Pubmed

Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-β1/Smad pathway.

SMAD2 SMAD3

4.54e-053136229115383
Pubmed

Osteosarcoma cells promote the production of pro-tumor cytokines in mesenchymal stem cells by inhibiting their osteogenic differentiation through the TGF-β/Smad2/3 pathway.

SMAD2 SMAD3

4.54e-053136224183998
Pubmed

TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells.

SMAD2 SMAD3

4.54e-053136234463252
Pubmed

Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha in HepG2 cells.

SMAD2 SMAD3

4.54e-053136221646355
Pubmed

Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain.

FN1 LPA

4.54e-05313629269765
Pubmed

Pin1 promotes transforming growth factor-beta-induced migration and invasion.

SMAD2 SMAD3

4.54e-053136219920136
Pubmed

Genomewide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis.

SMAD2 SMAD3

4.54e-053136225431176
GeneFamilyFibronectin type III domain containing

CNTN4 FN1 CNTN6 PTPRF PTPRM TNN CNTN5 CNTN3 TNXB SORL1

7.72e-091609110555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

CNTN4 OBSL1 CNTN6 HMCN2 PTPRF PTPRM CNTN5 CNTN3

1.51e-06161918593
GeneFamilyGlycogen phosphorylases

PYGB PYGM

7.49e-053912437
GeneFamilyVEGF family

PGF VEGFB

2.48e-0459121267
GeneFamilyImmunoglobulin like domain containing

CNTN4 OBSL1 HMCN2 PTPRM CNTN5 CNTN3

4.30e-04193916594
GeneFamilySMAD family

SMAD2 SMAD3

6.88e-048912750
CoexpressionAtlasdev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000

CNTN4 GPM6B MYADM ZCWPW1 USP11 FAT3 OBSL1 LAMB1 CNTN6 CRY1 PTPRF AEBP1 PGAP2 SVIL KIF14 PYGM

2.55e-0576813316gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlasdev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000

CNTN4 GPM6B ZCWPW1 FN1 USP11 FAT3 OBSL1 LAMB1 CNTN6 CRY1 AEBP1 SVIL KIF14 TNS3 SMAD3 GABRA1

3.75e-0579313316gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
ToppCellMesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class

FN1 ANPEP PRSS12 SLC48A1 HMCN2 AEBP1 SVIL FHL1 TNXB

8.96e-091971349cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPM6B PRSS12 FAT3 ECT2L FHL1 TNXB PRDM6 SMAD3

7.62e-08180134808ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPM6B PRSS12 FAT3 ECT2L FHL1 TNXB PRDM6 SMAD3

7.62e-0818013489b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

PRUNE2 CNTN4 FN1 FAT3 HMCN2 SVIL FHL1 RASAL2

1.06e-07188134834e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

GPM6B FN1 FAT3 LAMB1 PYGM FHL1 PRDM6 TNS3

1.15e-0719013481196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPM6B MYADM FN1 LAMB1 AEBP1 FHL1 TNXB TNS3

1.20e-07191134844a9a6768084dafc641ad455b65862bfd4cc0cb9
ToppCellControl-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GPM6B PRSS12 FAT3 AEBP1 FHL1 TNXB PRDM6 SMAD3

1.20e-07191134814057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNTN4 GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 PRDM6

1.25e-0719213483d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.41e-071951348df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.41e-0719513484243190ad291d56694e2155954dbaa879c9d3844
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 HMCN2 AEBP1 ACAN CNTN5 SVIL FHL1 PRDM6

1.47e-0719613481522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.47e-07196134842e9828222a9663525d571633e8a454c30bfa7f8
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FAT3 HMCN2 AEBP1 ACAN CNTN5 SVIL FHL1 PRDM6

1.47e-0719613481c8294014713684b50885e638668f2ce75f357f0
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.71e-07200134834f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellP15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPM6B FN1 FAT3 LAMB1 FHL1 PRDM6 TNS3

9.96e-0717413473c47d069bd836599a8d40eae485c23d4d3487517
ToppCellT_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

INPP5F PPM1H USP51 ELAPOR1 KLHL34 TNS3 MPG

1.07e-06176134756c055488e34605d32562571a2fee621b47c9441
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN AFMID AGXT

1.12e-0617713472f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9 AFMID

1.20e-061791347d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 FN1 LAMB1 AEBP1 TNN FHL1 PRDM6

1.30e-0618113479c157de9d3403e092c907599f2a2c16db5b21131
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 FN1 LAMB1 AEBP1 TNN FHL1 PRDM6

1.30e-061811347eea943fdcbef0bbaa8578f3296923e874893b405
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

FNIP2 FN1 PLBD2 GLA FHL1 SPIC VEGFB

1.39e-0618313474cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 FN1 LAMB1 AEBP1 TNN FHL1 PRDM6

1.39e-061831347bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN AFMID AGXT

1.39e-06183134785446581999cd66b171c4f69b7eb8b0bbbaa8617
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 CNTN4 FN1 AEBP1 ACAN FHL1 PRDM6

1.45e-06184134754e5b63f55b8d6eccad53d389ea9c78f991e1414
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 CNTN4 FN1 AEBP1 ACAN FHL1 PRDM6

1.45e-0618413477b5678718719020b52e7c2a7bd9797987defd7ff
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.55e-0618613475473283fb95cee556b1f6934cf72169b676b5bcc
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9 AFMID

1.55e-061861347a417e1e21313a7e05951038cdef5ac672a9f727c
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

GPM6B FN1 FAT3 LAMB1 FHL1 TNXB PRDM6

1.61e-06187134792d468dde81125d51daf7abd4703741abe1ab91c
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

KREMEN1 FN1 LAMB1 COLGALT2 AEBP1 TNXB PRDM6

1.61e-061871347e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9 AFMID

1.67e-061881347f3edcefeef2ce19086032d98b243c02a6d542b38
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9 AFMID

1.67e-0618813470792432cd4c564dea1102241ea9884f7ced7658c
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNTN4 GPM6B FAT3 LAMB1 AEBP1 FHL1 PRDM6

1.73e-061891347a153b83314cf52808f685296cff8c95af3f4983d
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

GPM6B FN1 LAMB1 PYGM FHL1 PRDM6 TNS3

1.73e-061891347dc5164591dea45b420798b94dda211be03daa70c
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

PRUNE2 CNTN4 FN1 FAT3 HMCN2 FHL1 RASAL2

1.73e-0618913476b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellCOPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class

FN1 LAMB1 PTPRM SVIL FHL1 RASAL2 TNS3

1.79e-0619013479fc763d65470ba8858b973689c4d4358faab7dd3
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.79e-0619013473a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNTN4 GPM6B FAT3 LAMB1 AEBP1 FHL1 PRDM6

1.79e-061901347841cd55861b43578d704418b9bc0af2e8b88323a
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPM6B FN1 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.85e-061911347997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNTN4 GPM6B FAT3 LAMB1 AEBP1 FHL1 PRDM6

1.92e-0619213476f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellPND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GPM6B FN1 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.99e-061931347ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7
ToppCellILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

PRUNE2 FN1 SLC30A8 LAMB1 AEBP1 FHL1 PRDM6

1.99e-061931347084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.99e-061931347ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCellPND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

GPM6B FN1 LAMB1 AEBP1 FHL1 TNXB PRDM6

1.99e-06193134730481fb01c7acf85beae10213f038da86bed6777
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPM6B FN1 PRSS12 LAMB1 AEBP1 FHL1 TNXB

1.99e-061931347160691b671710be10220803d788c2c961c236af1
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

GPM6B FAT3 LAMB1 IRS2 FHL1 TNXB PRDM6

2.06e-061941347e93de9428c986b8943fc169258847c650cfab0e5
ToppCellMesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class

FN1 ANPEP PRSS12 HMCN2 AEBP1 FHL1 TNXB

2.06e-061941347c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CNTN4 FN1 FAT3 LAMB1 AEBP1 FHL1 PRDM6

2.06e-0619413476e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellfacs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CNTN4 MYADM FN1 AEBP1 FHL1 TNXB PRDM6

2.13e-061951347223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.13e-06195134761c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

GPM6B FN1 FAT3 LAMB1 FHL1 TNXB PRDM6

2.13e-061951347603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB

2.20e-0619613479737a5f006d37b549f281e1863aca558e1e4dc99
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.20e-061961347bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SLC30A8 LAMB1 EHD2 AEBP1 SVIL FHL1 PRDM6

2.20e-06196134720dc9b25ecc23b6e6e52bbab8b5a404f3245ca37
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB

2.20e-061961347cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB

2.28e-06197134713896ec65ccda0b928c91d41112dc01b480036b7
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB

2.35e-061981347f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.43e-0619913474bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GPM6B FN1 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.43e-0619913470019cfaa586a450c2e4952d1184a540561c8d0ba
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

GPM6B FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB

2.43e-06199134766a79732caf2f04c09b4d9832377aa01ca477677
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.52e-062001347389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GPM6B FN1 FAT3 LAMB1 FHL1 TNXB PRDM6

2.52e-062001347e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellBronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

FN1 LAMB1 COLGALT2 HMCN2 AEBP1 FHL1 TNXB

2.52e-06200134754b18c92daaa3b3368c0c46134b0c27e10c8dbb0
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.52e-062001347cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.52e-062001347cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FN1 LAMB1 AEBP1 ACAN FHL1 TNXB PRDM6

2.52e-062001347c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FN1 FAT3 LAMB1 AEBP1 FHL1 TNXB PRDM6

2.52e-062001347311fab076f2ceb258e3970eb21e39344b894042a
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

GPM6B FN1 PRSS12 LAMB1 LPA FHL1 TNXB

2.52e-062001347bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_3|PND01-03-samps / Age Group, Lineage, Cell class and subclass

PCDHGA3 SLC30A8 PGF JPH1 RIN1 ROPN1L

3.72e-0613713469bfdbc102cdd861996b3c4eac35b606be8af97eb
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPM6B FN1 FAT3 PYGM FHL1 TNS3

9.41e-061611346b19f82dd98a3064581793711bb70373f18abecd9
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

PRUNE2 CNTN4 EPPK1 FN1 FAT3 HMCN2

9.41e-06161134647b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FAT3 PPM1H MELTF LPA ELAPOR1 TAS1R1

1.20e-0516813468072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class

FN1 FAT3 IPO9 ACAN TNS3 VEGFB

1.46e-051741346fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 FAT3 PPM1H CNTN5 TNS3

1.56e-051761346327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tnaive/CM_CD4|GI_large-bowel / Manually curated celltypes from each tissue

EPPK1 MKRN2 PGF AEBP1 SVIL PYGM

1.61e-051771346eb87ea93e36a8f97442ec8515f658ee61932dc0f
ToppCellChildren_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTN4 PRSS12 CNTN6 LPA ELAPOR1 CNTN3

1.66e-051781346fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PCDHGA3 FAT3 LAMB1 AEBP1 FHL1 TNXB

1.66e-05178134609475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PCDHGA3 FAT3 LAMB1 AEBP1 FHL1 TNXB

1.66e-05178134635de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PCDHGA3 FAT3 LAMB1 AEBP1 FHL1 TNXB

1.66e-051781346000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCellControl-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations)

PRUNE2 FN1 FAT3 AEBP1 SVIL PRDM6

1.77e-051801346d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9

1.83e-0518113469542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PRUNE2 FN1 LAMB1 AEBP1 CNTN3 TNXB

1.83e-051811346b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

CNTN4 FAT3 SLC30A8 CUBN AFMID CNTN5

1.83e-051811346c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCellP28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPM6B FN1 LAMB1 AEBP1 FHL1 PRDM6

1.83e-051811346091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN SLC7A9

1.83e-0518113468f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCellP28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPM6B FN1 LAMB1 AEBP1 FHL1 PRDM6

1.89e-05182134669f9d44694fe4f55a971ae0ac5dc3e7448ee78f3
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

PRUNE2 CNTN4 FN1 FAT3 HMCN2 RASAL2

1.95e-051831346818fd886e0188091310825f9145fa53328f2c979
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 FAT3 PPM1H CNTN5 TNS3

1.95e-051831346738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PRSS12 FAT3 FHL1 TNXB PRDM6 SMAD3

1.95e-0518313467eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 FAT3 PPM1H CNTN5 TNS3

1.95e-05183134692fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

PRUNE2 CNTN4 FN1 FAT3 HMCN2 RASAL2

1.95e-051831346cae2ee08f985a6f005b4b8e959e465350315156a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN AFMID

2.01e-0518413469434731f651820b05335085582960f08fbf895de
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FN1 SLC30A8 EHD2 AEBP1 SVIL FHL1

2.01e-0518413465cfc19ffb9f074bdf0d81c86e212a708ec141631
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRUNE2 HMCN2 AEBP1 SVIL FHL1 PRDM6

2.01e-051841346590fb32bb1f348ea5fa2aece30ebe1e212512991
ToppCellP03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

GPM6B FN1 FAT3 PYGM FHL1 TNS3

2.07e-051851346a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PRUNE2 CNTN4 ANPEP SLC30A8 CUBN CNTN5

2.13e-051861346b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DHRS13 INPP5F SAMD9L USP51 SLC27A5 IL9R

2.20e-051871346c667fae6440dc98072b584f203d00f0fb1cb2f21
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

FN1 FAT3 LAMB1 FHL1 TNXB PRDM6

2.20e-051871346bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCelldroplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPM6B FN1 ANPEP LAMB1 FHL1 TNXB

2.26e-051881346e54e09d34e263d5709c337914809e61e74e20591
ToppCelldroplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPM6B FN1 ANPEP LAMB1 FHL1 TNXB

2.26e-0518813467fc9810ab14354cb512e2b1285562009c10203f5
ToppCell(2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis

FN1 ANPEP HMCN2 AEBP1 FHL1 TNXB

2.26e-051881346409a7b69d02e87084ca955e3fe6c77230dee8861
Druggluconohydroximo-1,5-lactone

GBA2 PYGB PYGM

1.93e-0651333CID009576855
DrugDiflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A

GAD1 FN1 ZDHHC17 SLC48A1 RIN1 PTPRM IRS2 FHL1 SMAD3

2.45e-0619713394158_DN
Drughomonojirimycin

GBA2 GLA PYGB PYGM

2.50e-06171334CID000159496
Drugfagomine

GBA2 GLA PYGB PYGM

2.50e-06171334CID000072259
Drugstaurosporine; Up 200; 0.1uM; MCF7; HG-U133A

EPPK1 FN1 OBSL1 KDM6B SVIL IRS2 ZNF324B VEGFB

9.37e-061761338423_UP
Drug(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A

MON2 GPM6B GAD1 ACTL8 PTPRM FHL1 RASAL2 VEGFB

1.90e-0519413384134_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ZCWPW1 OBSL1 GMEB2 KDM6B PTPRF SBF1 MACO1 PYGB

1.97e-0519513381700_DN
Drugpyridoxine

GAD1 LPA AGXT PYGB PYGM VPS13B

2.01e-05951336CID000001054
DrugDecamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A

ADAM15 SLC48A1 SLC7A9 ACTL8 MACO1 ZNF324B FHL1 SORL1

2.04e-0519613387353_DN
Drugtopiramate; Down 200; 3uM; MCF7; HT_HG-U133A_EA

ZCWPW1 ANPEP LAMB1 SLC48A1 EHBP1L1 IPO9 ACTL8 SBF1

2.04e-051961338915_DN
DrugSulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

GPM6B GAD1 TMPRSS15 SLC7A9 RIN1 AGXT ARHGAP33 SMAD3

2.12e-0519713384979_UP
DrugIsoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

TMPRSS15 ABHD18 ADAM15 LAMB1 SPIDR RASAL2 ARHGAP33 DOP1B

2.20e-0519813385545_DN
DrugFlecainide acetate [54143-56-5]; Up 200; 8.4uM; HL60; HT_HG-U133A

PRUNE2 GPM6B TAF1C PFKFB4 TRIM5 MEGF8 CPLANE1 SMAD3

2.20e-0519813382557_UP
DrugSerotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A

LAMB1 KDM6B IPO9 ACTL8 MACO1 SVIL RASAL2 SMAD3

2.20e-0519813383311_DN
Drug8-azidoadenosine 5'-monophosphate

PYGB PYGM MPG

2.27e-05101333CID000124726
DrugGlu-Ala

TMPRSS15 ANPEP ACAN SOS1

2.36e-05291334CID000100098
DrugMoroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A

TMPRSS15 FN1 TAF1C TMEM104 MAPK12 SVIL SLC27A5 SOS1

2.36e-0520013382027_DN
Drugphosphorite

PNKP FN1 PYGB PYGM

4.50e-05341334CID000107908
Drugsodium chloride

GPM6B FN1 ANPEP COLGALT2 PFKFB4 GBA2 MAPK12 GLA PTPRM ODF4 ACAN PYGB PYGM IRS2 SMAD2 MPG

4.62e-0586513316CID000000206
Drugglucose-6-P

PFKFB4 GBA2 PLBD2 PHKB GLA ACAN PYGB PYGM SORL1 MPG

5.97e-0536613310CID000000208
Drugnojirimycin

GBA2 GLA PYGB PYGM

7.04e-05381334CID000065242
Drugcolchine

DPP7 GAD1 FN1 ANPEP LAMB1 MEFV ACTL8 ACAN CNTN3 GABRA1

8.69e-0538313310CID000002833
Drug3,5-dimethylphenyl isocyanate

PYGB PYGM

1.01e-0431332CID000521488
Drug5'-deoxy-5'-fluoro-5'-(methylthio)adenosine

PYGB PYGM

1.01e-0431332CID000147839
DrugNSC758405

PYGB PYGM

1.01e-0431332CID000003201
Drug3,5-dinitrophenyl phosphate

PYGB PYGM

1.01e-0431332CID000151920
Drugpyridoxal phosphoglucose

PYGB PYGM

1.01e-0431332CID000196007
Drug5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone

PYGB PYGM

1.01e-0431332CID000093111
Drugadenosine-5'-chloromethylphosphonate

PYGB PYGM

1.01e-0431332CID000191554
Drughydan

PYGB PYGM

1.01e-0431332CID000008360
DrugEHMF

PYGB PYGM

1.01e-0431332CID000033931
Drugpyridoxal 5'-methylenephosphonate

PYGB PYGM

1.01e-0431332CID003082249
DrugPlp 5'-mpa

PYGB PYGM

1.01e-0431332CID003082151
Drugglucose-1,2-cyclic phosphate

PYGB PYGM

1.01e-0431332CID000191723
Drug3'-FFdUrd

PYGB PYGM

1.01e-0431332CID000072260
Drug2',3',4',5,5'-pentachloro-2-biphenylol

PYGB PYGM

1.01e-0431332CID000119518
DrugAC1L8XK3

PYGB PYGM

1.01e-0431332CID000409735
DrugN-acetyl-N'-beta-D-glucopyranosyl urea

PYGB PYGM

1.01e-0431332CID000446801
Drugriboflavin tetraacetate

PYGB PYGM

1.01e-0431332CID000094186
Drug2,5-dimethyl-3-furanone

PYGB PYGM

1.01e-0431332CID000085730
Drug3,5-dinitrophenol

PYGB PYGM

1.01e-0431332CID000011459
Drugbutylethanolamine

PHKB PYGB PYGM

1.03e-04161333CID000249006
Drugmaltos

TMPRSS15 LAMB1 GBA2 PPM1H CRY1 GLA ACAN PYGB PYGM MPG

1.07e-0439313310CID000000294
Drugindoxyl-beta-D-glucoside

GBA2 AFMID MPG

1.25e-04171333CID000092769
Drugproglycosyn

PFKFB4 PHKB PYGB

1.25e-04171333CID000147052
Druginulin

PRSS12 AFMID ODF4 LPA PYGB PYGM

1.33e-041331336CID000024763
DrugMethoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A

GPM6B FN1 SLC48A1 TRIM5 SLC7A9 ELAPOR1 ARHGAP33

1.47e-0419413373302_UP
DrugSulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; HL60; HT_HG-U133A

FN1 ABHD18 NCBP1 RIN1 PGAP2 DOP1B TRMT12

1.52e-0419513371859_DN
DrugAmethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A

GAD1 PFKFB4 SLC48A1 ACTL8 ACAN ZNF324B VPS13B

1.57e-0419613375000_UP
DrugSR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A

ZCWPW1 LAMB1 EHBP1L1 SBF1 KBTBD11 IRS2 VEGFB

1.57e-0419613373272_DN
DrugRibavirin [36791-04-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A

TMPRSS15 FN1 TRIM5 ACTL8 SBF1 ZNF324B VPS13B

1.57e-0419613376018_UP
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

ABHD18 SLC48A1 RIN1 ACTL8 PYGB SMAD3 SOS1

1.57e-0419613372764_DN
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A

OBSL1 PGF PPM1H ACAN MACO1 HHIPL2 SLC27A5

1.57e-0419613371913_UP
Drug2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A

GPM6B COLGALT2 PFKFB4 KDM6B SBF1 RASAL2 ARHGAP33

1.57e-0419613374446_DN
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A

ZDHHC17 KDM6B IPO9 SBF1 SPIDR SMAD3 SORL1

1.62e-0419713372887_DN
DrugMycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

TMEM104 ACTL8 MACO1 KBTBD11 SPIDR FHL1 TNS3

1.62e-0419713374137_DN
DrugTriamcinolone [124-94-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A

PRUNE2 GPM6B FN1 RIN1 MEGF8 ACAN FHL1

1.62e-0419713372241_UP
DrugCyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A

ZCWPW1 FN1 LAMB1 ZDHHC17 SBF1 SPIDR FHL1

1.62e-0419713375525_DN
DrugNizatidine [76963-41-2]; Down 200; 12uM; MCF7; HT_HG-U133A

EPPK1 TAF1C SLC48A1 ACTL8 SBF1 AEBP1 VEGFB

1.62e-0419713375406_DN
DrugAlprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A

PRUNE2 NCBP1 TMEM104 SBF1 IRS2 CPLANE1 DOP1B

1.62e-0419713377358_UP
Drugsulfasalazine; Up 200; 100uM; MCF7; HG-U133A

BCL2L14 PFKFB4 SLC48A1 EHD2 ACTL8 FHL1 ARHGAP33

1.62e-041971337204_UP
DrugAC1Q6SL6

TMPRSS15 PYGB PYGM MPG

1.63e-04471334CID000000198
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A

TAF1C KDM6B TRIM5 EHBP1L1 ACTL8 SVIL FHL1

1.67e-0419813376023_DN
DrugSulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A

MON2 FN1 MEGF8 ELAPOR1 FHL1 SMAD3 GABRA1

1.67e-0419813373218_UP
DrugTranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A

TMPRSS15 FN1 OBSL1 SLC7A9 PTPRM AEBP1 SPIDR

1.67e-0419813375996_UP
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A

GPM6B GAD1 KDM6B SLC48A1 ACTL8 IRS2 SMAD3

1.67e-0419813372845_UP
DrugLevopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A

FN1 PRSS12 TMEM104 PYGB VPS13B ARHGAP33 SMAD3

1.67e-0419813372980_UP
DrugTolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A

ZCWPW1 TAF1C PGF RIN1 MAPK12 ACTL8 ZNF324B

1.67e-0419813374805_DN
Drugmeprobamate

TMPRSS15 PTPRM PYGB PYGM GABRA1

1.68e-04881335CID000004064
DrugHexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A

OBSL1 KDM6B IPO9 PTPRF ACTL8 FHL1 DOP1B

1.72e-0419913376244_DN
DrugIobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A

FN1 CUBN SBF1 ACAN MACO1 ARHGAP33 SLC27A5

1.72e-0419913371729_UP
DrugBambuterol hydrochloride [81732-46-9]; Up 200; 10uM; HL60; HG-U133A

TMPRSS15 TAF1C TMEM104 SBF1 ACAN SMAD3 SOS1

1.72e-0419913371582_UP
DrugOrnidazole [16773-42-5]; Up 200; 18.2uM; HL60; HG-U133A

BCL2L14 FN1 KDM6B ZNF324B FHL1 TNS3 SOS1

1.72e-0419913371425_UP
DrugLymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A

FN1 SLC48A1 ELAPOR1 KBTBD11 SPIDR VPS13B RASAL2

1.72e-0419913375994_UP
DrugChenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A

TMPRSS15 FN1 ABHD18 IPO9 ACTL8 AGXT VPS13B

1.72e-0419913376012_UP
DrugBenzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; HL60; HT_HG-U133A

GPM6B TMPRSS15 PTPRM SVIL HHIPL2 PYGB RASAL2

1.78e-0420013372200_UP
Druggalocitabine

PYGB PYGM

2.02e-0441332CID000065950
Drug5-deoxyribose-1-phosphate

PYGB PYGM

2.02e-0441332CID000135786
Drugingliforib

PYGB PYGM

2.02e-0441332CID006451325
Druguric acid riboside

PYGB PYGM

2.02e-0441332CID000164933
Drugpseudo-dl-glucose

PYGB PYGM

2.02e-0441332CID000125259
Drugpyridoxal diphosphate

PYGB PYGM

2.02e-0441332CID000125696
DrugN'-Pyridoxyl-Lysine-5'-Monophosphate

AGXT PYGM

2.02e-0441332DB04083
Drug2,5-anhydro-D-mannitol 1-phosphate

PYGB PYGM

2.02e-0441332CID000189134
DrugAC1LAMW2

PYGB PYGM

2.02e-0441332CID000491364
DrugFdUrd-C8

PYGB PYGM

2.02e-0441332CID000094262
DrugMem-CC

PYGB PYGM

2.02e-0441332CID003081269
DrugBCIp4A

PYGB PYGM

2.02e-0441332CID000192417
Drug3'-chloromethotrexate

PYGB PYGM

2.02e-0441332CID000097703
Drugmethyl salicylate

HLA-DRB3 MAPK12 AGXT CNTN3

2.25e-04511334CID000004133
DrugI0329

GLA PYGB PYGM

2.40e-04211333CID000439668
Drugdiphenyl phosphonate

DPP7 PGF PYGB

2.40e-04211333CID006327546
Drughonokiol

FN1 SMAD2 SMAD3 GABRA1

2.42e-04521334ctd:C005499
DrugPyridoxal Phosphate

GAD1 AGXT PYGB PYGM

2.61e-04531334DB00114
Drugneotrehalose

ZDHHC17 GBA2 TCERG1 PYGB CNTN3 PYGM MPG

2.69e-042141337CID000001143
Diseaseplatelet component distribution width

PRUNE2 ZCWPW1 KREMEN1 CUBN MELTF MAVS TNN CNTN5 SVIL PYGB IRS2 TNXB SPIC

3.05e-0575513013EFO_0007984
Diseaseurinary microalbumin measurement

MON2 CUBN PPM1H

9.02e-05201303EFO_0010967
DiseaseHbA1c measurement

ADAM15 MKRN2 SLC30A8 DHRS13 TRIM5 AFMID AEBP1 MACO1 CNTN5 TAS1R1 SOS1

2.05e-0467513011EFO_0004541
DiseaseLoeys-Dietz Syndrome

SMAD2 SMAD3

3.99e-0471302C2697932
Diseasegait measurement

ADAM15 HLA-DRB3 PGF KIF14 GABRA1

5.46e-041501305EFO_0007680
Diseasemyocardial infarction

FN1 TRIM5 EHBP1L1 IPO9 LPA TSPAN14 SMAD3

9.45e-043501307EFO_0000612
Diseasepolybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement

TRIM5 PTPRM

1.03e-03111302EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
DiseaseAutistic Disorder

CNTN4 GAD1 TAF1C LAMB1 CNTN3 GABRA1

1.08e-032611306C0004352
Diseasenon-alcoholic fatty liver disease, cirrhosis of liver

EHBP1L1 CNTN5 SVIL

1.67e-03531303EFO_0001422, EFO_0003095
Disease1-methylurate measurement

CNTN4 PTPRF

1.69e-03141302EFO_0021173
Diseasesugar consumption measurement

CNTN4 PTPRF KIF14 VPS13B

1.99e-031201304EFO_0010158
Diseaseurate measurement, spine bone mineral density

SLC7A9 PRDM6 SLC27A5

2.16e-03581303EFO_0004531, EFO_0007701
Diseaseangina pectoris

EHBP1L1 IPO9 LPA FHL1

2.31e-031251304EFO_0003913
DiseaseGlycogen storage disease

PHKB PYGM

2.51e-03171302cv:C0017919
Diseaserenal cell carcinoma (is_marker_for)

FN1 KDM6B PGF SMAD2

2.52e-031281304DOID:4450 (is_marker_for)
DiseaseMalignant neoplasm of breast

FN1 COLGALT2 PFKFB4 MAGEE1 CUBN CNTN6 PHKB ELAPOR1 VPS13B RASAL2 SORL1 VEGFB

2.86e-03107413012C0006142
Diseasecerebral infarction (is_marker_for)

LPA SOS1

3.14e-03191302DOID:3526 (is_marker_for)
Diseaserheumatoid arthritis (is_marker_for)

PGF ACAN LPA

3.54e-03691303DOID:7148 (is_marker_for)
DiseaseLeft Ventricle Remodeling

SMAD2 SMAD3

3.83e-03211302C0600520
DiseaseVentricular Remodeling

SMAD2 SMAD3

3.83e-03211302C0600519
DiseaseNephritis, Tubulointerstitial

SLC7A9 GLA

3.83e-03211302C0041349
Diseasedepressive disorder (implicated_via_orthology)

GPM6B RNF103

4.20e-03221302DOID:1596 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
ISDGYFIQTPTWCIV

C21orf140

61

B9A014
PVSIEERARWTETYV

EIF3B

326

P55884
YEWEPRVVSTEVVRA

ELMOD3

61

Q96FG2
DTFSYPIERGRILNW

ACTL8

61

Q9H568
TLVWYQPDGTRVVSE

ADAM15

96

Q13444
VARFIRIYPLTWNGS

AEBP1

516

Q8IUX7
PYNTECSWLIVVAEG

CDCP2

51

Q5VXM1
TPEVLRVYIGSFWSQ

EHD2

246

Q9NZN4
AYIPRTGVRSLQEIW

ABHD18

376

Q0P651
EGLGRNWYVTPEITI

AJM1

521

C9J069
TFTATVVGLNPWVEY

CNTN4

656

Q8IWV2
VVGLNPWVEYEFRTV

CNTN4

661

Q8IWV2
ISIANRVAEIVYSWP

BCL2L14

151

Q9BZR8
LNRTGRSIVYSCEWP

GLA

191

P06280
IWGCPTLSEVNRYLI

ECT2L

771

Q008S8
NYVWIVPITSIRDGR

ANPEP

581

P15144
RIWLTYREEFPQIEG

ATG4C

86

Q96DT6
WVEYEFRVVATNPIG

CNTN5

741

O94779
VYPITCGDSRANLIW

GMEB2

91

Q9UKD1
CRVISEFVIPSVYWV

MKRN2

291

Q9H000
QYCPSRWVVRLGAEE

AFMID

26

Q63HM1
LERNVSIPIGWSYFI

ODF4

171

Q2M2E3
LRCEVAPAGSQVRWY

OBSL1

1101

O75147
AIGGEVPQRYVWRFC

PGAP2

66

Q9UHJ9
QRSVFIPYRESVLTW

KIF14

646

Q15058
CERPGESWVVYGVTS

PRSS12

831

P56730
WRDSRQVPTRNVVGY

KLHL34

581

Q8N239
TLQRRPGWVEYFIAA

MAVS

61

Q7Z434
QYEFVWGPRARLETS

MAGEE1

896

Q9HCI5
VPVTSSGTWYCLERR

KIAA0895

156

Q8NCT3
SGTWYCLERRPAVFV

KIAA0895

161

Q8NCT3
VRCETDGTSVLTPWY

NCBP1

726

Q09161
PSRVYWIASVIQTAG

L3MBTL2

226

Q969R5
SCRVLGEAPYNLTWV

HMCN2

536

Q8NDA2
QIYRWAFIPEVDTEG

DOP1B

2171

Q9Y3R5
CVAGIQKTTYVWREP

ELAPOR1

871

Q6UXG2
PGVYARVSRFTEWIQ

TMPRSS15

1001

P98073
VYRFVQRPGDLVWIN

KDM6B

1451

O15054
VRQSLCTPARYEGTW

JPH1

96

Q9HDC5
TNVCFWYIPQSLRGV

GAD1

511

Q99259
QYVWHTERGVCLPTV

MACO1

111

Q8N5G2
SIDRWVAVVFPLSYR

GPR26

101

Q8NDV2
RYLNWIGVPTREFNV

PFKFB4

61

Q16877
WCQEVTTGYRGVRIT

EHBP1L1

1046

Q8N3D4
VREVWPRGLITYVTV

MEGF8

2566

Q7Z7M0
SVTGRQFVEKWYPVS

RASAL2

256

Q9UJF2
VERQYIQDRIPSWTG

LAMB1

571

P07942
TGRVCYWTIRVPGAS

KREMEN1

236

Q96MU8
YATEVAWTRARPGEI

MYADM

151

Q96S97
YEWTREPARSVVVAE

GABRA1

196

P14867
PSFLSGRRYWEVEVG

MEFV

646

O15553
EYRGTWIPILTITVQ

MON2

446

Q7Z3U7
CVDIRQYGIIPWNAF

GPM6B

186

Q13491
FLVWTVVYRQPGTAA

SLC48A1

26

Q6P1K1
AGWLRDQTVRYPIVS

ACAN

526

P16112
RGQVPCRSVWEYVDR

SBF1

1546

O95248
TYSVQFGDLWPSIRV

NSUN4

51

Q96CB9
CIDIPRGTELLVWYN

PRDM6

351

Q9NQX0
EYRVSVWENVPVGTR

PCDHGA3

246

Q9Y5H0
LVAPATAAYREVWQV

IRS2

186

Q9Y4H2
SGRPWRSYFDLIVVD

NT5DC4

241

Q86YG4
QVTCQGRSWPVLRSY

ARHGAP33

86

O14559
ECIWYIRTDPGSSIQ

CUBN

1416

O60494
YCEWVLVAPAGRLVT

CUBN

3536

O60494
GGERTCPSWVVVLYR

FHL1

271

Q13642
YRAVTELGRPVAESW

HLA-DRB3

76

P79483
VVPATLIRSYWVGDI

CPLANE1

306

Q9H799
YQDSSLPVGVFVWDV

GBA2

261

Q9HCG7
IAWESPQGQVSRYRV

FN1

1741

P02751
EFRGTIWNLYSVPRI

FNIP2

381

Q9P278
VTFGDRVLYPASWIV

SLC7A9

291

P82251
QGADTIRCVYILDPW

CRY1

26

Q16526
EIYRFIVRASDWGSP

FAT3

541

Q8TDW7
CPQVVISFYEERLTW

CBX1

156

P83916
RFYVRGSPWVSVVDR

MPG

276

P29372
TRDPGVRWEYCNLTQ

LPA

546

P08519
TVVGLSPWVEYEFRV

CNTN6

661

Q9UQ52
SPWVEYEFRVVAGNS

CNTN6

666

Q9UQ52
LEPWTTYCVQVRGFL

IL10RB

181

Q08334
PSVRISAVRAIWGYC

IPO9

531

Q96P70
PDYVQIREWKRTGCF

COLGALT2

216

Q8IYK4
EQVGVVWVYLPDGSR

HHIPL2

236

Q6UWX4
VLRGWSNPTICFVYD

ERVFC1

76

P60507
VWYETGIFATQLVDP

RNF103

26

O00237
TRGSVPVFWSQVGYR

INPP5F

326

Q9Y2H2
DVDVFQWPLGVATYR

RXYLT1

236

Q9Y2B1
VSYVRWEGVFRCIPI

SLC38A10

186

Q9HBR0
YVVAFRPLGVTTWIQ

CNTN3

736

Q9P232
YDTVRWEFGTCQPLS

DPP7

236

Q9UHL4
PVVGWRQELRAYADT

DHRS13

186

Q6UX07
RTPTGFYDRVWQILE

PHKB

936

Q93100
WFYIVVVPIDRVGGS

PTPRF

1131

P10586
ITIRWEPFGYNVTRC

PTPRM

396

P28827
NYNWAITREGLVVRP

MRPS26

186

Q9BYN8
ERPIWLRESTVQGAY

GTF2E1

276

P29083
VTTVAVPAGYDWRDI

AGXT

321

P21549
TAVECTWTGPRNVVY

SORL1

1856

Q92673
YRRAEWPETQGAVTE

RIN1

701

Q13671
RFTVRQLEPWGLEYQ

PRUNE2

1166

Q8WUY3
RTVGWNVPVGYLVES

MELTF

136

P08582
WRLYCVRGEVPVEGN

SVIL

1881

O95425
QCEIFLGIIYTSTPW

SAMD9L

941

Q8IVG5
VCLWSPEDGLRQIYR

TAF1C

361

Q15572
VPVWDVLASGYVSRA

EPPK1

3601

P58107
WVEPRLGRLYCQFSE

PNKP

506

Q96T60
GCTEWRVQTLAYLPQ

IL9R

396

Q01113
VLPTEEPVYNWRTVI

SPIC

56

Q8N5J4
GVIVDYNTTDPLIRW

TNS3

316

Q68CZ2
YRAVQPSELVGSVWT

SOS1

796

Q07889
AIYCVSRAGTWRFQP

KBTBD11

561

O94819
LTDVRRYWVDVTVAP

TRIM5

291

Q9C035
IWVVTGVLVYLACER

SLC30A8

151

Q8IWU4
LRLIYQRFVWSGTPE

USP51

211

Q70EK9
VQYNRCDIPEETWTG

ZCWPW1

291

Q9H0M4
CSRGRVYPWQLLEQI

TAS1R1

411

Q7RTX1
FSLVPVQWRTAYAGV

MPV17L

141

Q2QL34
SVIGRCYVQPQWVFD

PES1

386

O00541
RTIAQYAREIWGVEP

PYGM

816

P11217
IRTQPADVLRWSAGY

ROPN1L

31

Q96C74
VSWDPVRATIDRYVV

TNN

726

Q9UQP3
VVWTGDERVFFYNPT

TCERG1

536

O14776
TRRLPWATGYAEVIN

PPM1H

71

Q9ULR3
QRFGPIRIWEVYGST

SLC27A5

421

Q9Y2P5
VPFQEVWGRSYCRAL

PGF

41

P49763
SWPGAGVRVVVQRVY

SPIDR

476

Q14159
YRRQTVTSTPCWIEL

SMAD2

426

Q15796
GAEYRRQTVTSTPCW

SMAD3

381

P84022
RLRVVWTAQPDTFAY

TNXB

976

P22105
REGGTYPWVVDRVVF

TMEM104

386

Q8NE00
RTITEYAREIWGVEP

PYGB

816

P11216
YAREIWGVEPSDLQI

PYGB

821

P11216
SLTYWVPERLRQGFC

TSPY8

6

P0CW00
FRPVIVDWTRQYTIE

ZDHHC17

606

Q8IUH5
VSWIDVYTRATCQPR

VEGFB

36

P49765
YCTVWLQTVPGEIDS

VPS13B

2006

Q7Z7G8
VAVVTEPWFTQRYRE

TRMT12

21

Q53H54
ESWLPRNIYIVAGVF

TSPAN14

226

Q8NG11
YVRPRGCVLEWVRNI

PLBD2

336

Q8NHP8
VPRDRFTWEGLYNVL

USP11

621

P51784
SQERKPTGVSVIYWE

ZNF324B

131

Q6AW86
WEVRAVYRDLQPVGS

MAPK12

21

P53778
VAAVYWAVQGRPFEV

SLC8A2

836

Q9UPR5